Search Results 251-260 of 19706 for Receptor
Gala K, Camilleri M, Goyal M, Ohri A, Marek G, Ravi K. Glucagon-Like Peptide-1 Receptor Agonist Use is Associated With and May Lead To Esophageal Motility ...
Researchers seek to improve success of chimeric antigen receptor-T cell therapy in non-Hodgkin lymphoma. Joe Dangor. May 12, 2022. Research.
Researchers seek to improve success of chimeric antigen receptor-T cell therapy in non- · Research · Research · Science Saturday: What you should know about ...
... receptor-T cell therapy featured image. Biotherapeutics. Science Saturday: Addressing the challenges of chimeric antigen receptor-T cell therapy. Marla ...
... receptor-. Cancer. Mayo Clinic Q and A: New blood cancer treatment options with chimeric antigen receptor-T cell therapy. Cynthia Weiss. July 30, 2020. Mayo ...
T-cell receptor diversity may be key to treatment of follicular lymphoma, Mayo study finds. Joe Dangor. February 19, 2019.
Alpelisib is used together with other medicines (eg, fulvestrant) to treat hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)- ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.